Almost exactly one-year ago NDRA received this same form 8-K "Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing." *Shortly after recieving this notice, NDRA's Price shot up dramatically.
In September, ENDRA Life Sciences is planning to present the final results of the #Robarts study in conjunction with the upcoming EASL-NAFLD Summit in Seville, Spain.
Pattern is very similar to last year's notification.
Disclosure: I am long NDRA. This is not a note to buy or sell. Please do your own Homework before investing.
コメント
⋅
I was watching that movie “Steve Jobs” and made me think of this company, especially with novel imaging they have for NAFLD and the ex-GE Execs involved. Guess we’ll find out ; )